CClinicalTrials.gg
CompletedNCT00369083Updated Aug 29, 2006

Hospitalization at Home of Elderly Patients With Exacerbated COPD

An interventional study of Hospital at home treatment in COPD Exacerbation, sponsored by Azienda Ospedaliera San Giovanni Battista. Completed. Open to participants aged 75 Years and older. Per ClinicalTrials.gov, last updated 2006-08-29.

Sponsored by Azienda Ospedaliera San Giovanni Battista · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
75 Years and older
Sex
All
01

Study summary

Aim of the study was to evaluate the efficacy of hospital-at-home treatment compared with inpatient care in selected elderly patients with acute exacerbation of chronic obstructive pulmonary disease (COPD).

Read the detailed description

A total of 104 patients with an exacerbation of chronic obstructive pulmonary disease (COPD) selected from the Emergency Department (ED) of the hospital were randomized to home treatment from a Geriatric Home Hospitalization Service (GHHS) or to General Medical Ward (GMW).

The sample size estimation was performed according to the increasing 1-year (June 2002-May 2003) incidence of COPD exacerbation in hospital at home. On this basis, al least 100 patients needed to be included in the study to allow to detect a 20% difference in the endpoint hospital iatrogenic diseases, with a statistical significance  = 0.05 and a power 1-  = 0.8 using a two-sided test.

This study is considered a single-blind study because patients were aware of the treatment assignment while physicians and nurses evaluating patients were blinded to the patient's allocation.

In the ED all patients underwent baseline standard clinical evaluation; blood tests (blood cell count, routine biochemical tests and arterial blood gas tensions); pulse oximetry; 12-lead electrocardiography; chest radiographs and hand-held spirometry (SpirHOMEter, COSMED, Italy). Further investigations (including pneumologist's assessment) were performed when required, according to the clinical judgement of the ED physician. Only patients with a COPD exacerbation evaluated in ED for at least 12-24 hours and with stable clinical conditions were considered elegible to be included in the study.

Additional exclusion criteria were: 1) living outside the hospital catchment area; 2) absence of family and social support; 3) absence of informed consent; 4) necessity of intensive monitoring or mechanical ventilation; 5) history of dementia; 6) severe renal or hepatic failure; 7) cancer.

Patients fullfilling inclusion criteria were informed about the nature of the study and asked to give their informed consent. Extensive information was also provided to patients' relatives to obtain their collaboration. Patients fullfilling the inclusion criteria and having none of the criteria for exclusion were randomised, using a set of computer-generated random numbers, in a 1:1 ratio either to the treatment group (home-based hospitalization (GHHS)) or to the control group (conventional care (GMW)), using blinded sealed envelopes. Intention-to-treat analysis was used.

02

Conditions studied

  • COPD Exacerbation

Keywords

  • Frail elderly
  • Hospital at home
03

In context

Lead sponsor

Azienda Ospedaliera San Giovanni Battista is the lead sponsor of 24 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
75 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Exacerbation of COPD
  • Age >= 75 years
  • Living in hospital catchment area
  • Informed consent
  • Adequate social or familial support

Exclusion criteria

Exclusion Criteria:

  • Patients requiring assisted ventilation or intensive monitoring
  • History of dementia
  • Severe renal or hepatic failure
  • Cancer
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single
Enrollment
100 participants

Interventions

  • ProcedureHospital at home treatment
06

What researchers measure

Primary outcomes

  1. Mortality

  2. Hospital readmissions at six months

Secondary outcomes

  1. Length of hospital admission

  2. Caregiver stress

  3. Costs

  4. Patient's quality of life

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2006, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00369083
Lead sponsor
Azienda Ospedaliera San Giovanni Battista
First posted
Aug 29, 2006
Start date
Apr 2004
Completion
Oct 2005
Last update
Aug 29, 2006

Study contacts

Nicoletta Aimonino Ricauda, MD
principal investigator · San Giovanni Battista Hospital, Torino
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2004. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion